Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dose-dense doxorubicin/cyclophosphamide + sunitinib|DRUG: Dose-dense doxorubicin/cyclophosphamide
Sponsor: National University Hospital, Singapore